ether has been researched along with cidofovir anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beadle, JR; Bidanset, DJ; Hostetler, KY; Kern, ER; Wan, WB | 1 |
| Beadle, JR; Ciesla, SL; Gustin, KM; Hartline, CB; Hostetler, KY; Kern, ER; Wan, WB | 1 |
| Almond, M; Buller, RM; Lampert, B; Oberle, C; Painter, G; Parker, S; Robertson, A; Touchette, E; Trost, LC | 1 |
3 other study(ies) available for ether and cidofovir anhydrous
| Article | Year |
|---|---|
Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Esters; Ether; Humans; Lipids; Male; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Prodrugs; Treatment Outcome | 2004 |
Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Topics: Adenine; Adenoviruses, Human; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Esters; Ether; Humans; Lipids; Microbial Sensitivity Tests; Nucleosides; Organophosphonates; Prodrugs; Virus Replication | 2005 |
Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model.
Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Ether; Female; Hepatocytes; Humans; Mice; Mice, Inbred A; Organophosphonates | 2008 |